Checchi Capital Advisers, LLC Genmab A/S Transaction History

Checchi Capital Advisers, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 09, 2021	SELL	$41.55 - $48.72 $203,802 - $238,971	-4,905 Closed	0 $0
Q2 2021 Aug 06, 2021	BUY	$32.88 - $44.57 $161,276 - $218,615	4,905 New	4,905 $200,000
Q1 2021 May 10, 2021	SELL	$30.92 - $44.4 $172,100 - $247,130	-5,566 Closed	0 $0
Q4 2020 Feb 12, 2021	SELL	$33.66 - $40.76 $4,678 - $5,665	-139 Reduced 2.44%	5,566 $226,000
Q3 2020 Nov 10, 2020	BUY	$33.07 - $38.68 $188,664 - $220,669	5,705 New	5,705 $209,000

236

52.5M

10.2K

25.5K

Ticker GMAB
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 658,292,992
Market Cap $13.6B
Description
Genmab A/S develops antibody therapeutics for the treatment of cancer and other diseases primarily in Denmark. The company markets DARZALEX, a human monoclonal antibody for the treatment of patients with multiple myeloma (MM); teprotumumab for the treatment of thyroid eye disease; ofatumurnab, a human monoclonal antibody to treat chronic lymphoc...

Get notified when there are updates to the investment portfolio of Checchi Capital Advisers, LLC, based on Form 13F filings with the SEC.

Stay updated on Checchi Capital Advisers, LLC with notifications on news.